28
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Pretargeted Radioimmunotherapy (PRIT™) Using an Antibody-Streptavidin Fusion Protein in Non-Hodgkin's Lymphoma

Pages 1971-1973 | Published online: 03 Aug 2009

  • [Line 11185]Breitz, H.B., Weiden, P.L., Beaumier, P.I., et al (2000) "Clinical optimization of pretargeted immunotherapy (PRIT*) with antibodystreptavidin conjugate and 8Y-DOTA-biotin", J. Nucl. Med. 41, 131-140.
  • [Line 11215]Weiden, P.L., Braitz, H.B., Press, O., et al. (2000) "Pretargeted radioimmunotherapy (PRIT(tm)) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study results", Cancer Biother. Radiopharm. 15, 15-29.
  • [Line 11245]Press, O.W., Corcoran, M., Subbiah, S., et al. (2001) "A comparativeevaluation of conventional and pretargeled radioimmunotherapy of CD20-expressing lymphoma xenografts". Blood 98, 2535-2543.
  • [Line 11275]Schultz, J., Lin, Y., Sanderson, J., et al. (2000) "A tetravalent singlechain antibody-streptavidin fusion protein for prelargeted lymphoma therapy". Cancer Res. 60, 6663-6669.
  • [Line 11305]Weiden, P.L. and Breitz, H.B. (2001) "Pretargeted radioimmunotherapy (PRIT") for treatment of non-Hodgkin's lymphoma (NHL)", Crit. Rev. Oncol. Hematol. 40, 37-51.
  • [Line 11334]Campa, E., Raffeld, M. and Jaffe, E.S. (1999) "Mantle-cell lymphoma". Semin. Hematol. 36, 115-127.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.